Nonetheless, IFN-γ is capable to restore HLA class I expression [10] and sensitivity to CTL-mediated recognition of SCLC [11, 12], as well as of other tumor cells showing down-regulated HLA class I antigen expression [13]. This evidence concerns the gene IFNG and neoplasm.